The leaves of Parkia biglobosa (Pb) are traditionally used in the treatment of high blood pressure and zoster in Côte d'Ivoire. Our study aims at determining the effect of aqueous extract of leaves of Parkia biglobosa on markers of cellular immunity. Two sets of five (5) batches of six (6) rabbits were formed. The first series each received a single dose of Pb (25, 50, 75 and 100 mg/kg of body weight or BW) and NaCl 0.9%. The second group received Methylprednisolone (15 mg / kg of BW) or MP15 and mixtures of MP15 and Pb (50,75 and 100 mg/kg of BW), and MP15 and Isoprinosine (50mg/kg BW) or Ip50. The rabbit whole blood was collected, from the marginal vein of rabbit ear, in EDTA tubes on the first day before injection (Do), then the 3rd, 9th, 15th and 21th days for the determination of CD4+ count by flow cytometry and the total lymphocyte counts by hemogram. Results showed that single doses of Pb (25, 50, 75 and 100mg/kg BW) induced in the 3rd and 9th days, a significant increase of total lymphocytes and TCD4+ count compared with NaCl 0, 9%. The dose of Pb75 induced the highest count of lymphocytes and CD4+ (P<0.0001). However, in the presence of methylprednisolone, the same dose of Pb (50, 75 and 100 mg/kg BW) did not induce a change in the count of immune cells compared to control (NaCl 0.9%) in contrast to Ip. The results suggest that the aqueous extract of leaves of Parkia biglobosa stimulate the production of total lymphocytes and TCD4+.
INTRODUCTION
Microbial infections and particularly that of virus infection generally affect the immune system (Jovanka et al, 2009 ). The different immune cells that testify to these infections are T lymphocyte cells (Behnam et al., 2008; Jeroen et al., 2009 ) Thus, in the case of HIV infection, TCD4+ cells, the virus host cells, are degraded (Espert et al., 2006; Lelievre et al., 2003) . That is why the victim are subjected to the occurrence of opportunistic diseases such as herpes zoster, tuberculosis, cryptococcosis, candidiasis ( G h a t e e t a l . , 2 0 0 9 ) . T o o v e r c o m e t h i s immunosuppression, several plants of the African pharmacopoeia suspected to be immunostimulant, are used such as Cochlospermum tinctoriu A. Rich.
(Cochlospermaceae) in Mali (Nergard et al., 2005) , Hibiscus sabdariffa Linn (Malvacea) in Nigeria (Fakeye, 2008) . To this end, according to Millogo-Kone et al.,(2007) , leaves of Parkia biglobosa are used in recipes in Africa for the treatment of zoster. About this plant (Parkia biglobosa), Adjanohoun et al.,(1987) reported several healing effects of the bark of Parkia biglobosa including treatment of amoebiasis, hookworm, the arscadiose, asthma, infertility and peptic ulcers Some studies have shown that extracts of hexane, methanol and aqueous extract of bark has analgesic and anti inflammatory properties (Kouadio et al., 2000) . In addition, there also exist a relationship between the nutritional properties of this plant and its medicinal properties. That is the case of the seeds of Parkia biglobosa where, when used in sauces helped in the treatment of high blood pressure (Bonnah et al., 1998; Tra Bi et al., 2008) . Other studies have shown that treatment of high blood pressure could be made with the leaves of Parkia biglobosa in decoction (Tra Bi et al., 2008) and also with the aqueous extract of the bark (Kassi et al., 2008) . In recent decades, with the advent of HIV, the immune system of HIV positive people experienced depression. Therefore, the count of TCD4+ primary marker of immunosuppression of HIV, plays a crucial role in antiretroviral (ARV). They are not only helping to reduce HIV viremia, but also strengthen the immune system by increasing the count of TCD4+ (Espert et al., 2006) . However, ARV drugs have many side effects including drug reactions (maculopapular rash, Steven Johnson Syndrome) and lipodystrophy (Kane et al., 2007) . Moreover, the taking of ARVs is constrained because of the different negative reactions such as fatigue, nausea, diarrhea, fever, insomnia ( Bonolo et al., 2005; Cristiane et al., 2007) they present. It is therefore important to maintain the count of TCD4+ as high and above 350copies/µl in the whole blood for HIV positive people to avoid taking ARVs. To maintain or strengthen the immune system, several studies including those on melatonin showed that it reacts directly or indirectly to immune function (Dubbel et al., 1995) resulting in an increased production of TCD4+ in rabbits (Ugbomoiko et al., 2007) . Moreover, in view of helping those whose immune s ystem has been compromised to strengthen their compromised immune system, several studies have also been made on plants such a s C o c h l o s p e r m u m t i n c t o r i u m A . R i c h . (Cochlospermaceae) (Nergard et al., 2005) and Hibiscus sabdariffa LINN (Malvaceae) (Fakeye, 2008) . In Cote d'Ivoire, traditional healers used the leaves of Parkia biglobosa in the treatment of zoster, a disease resulting from immunosuppression. This led us to the hypothesis that these leaves are likely to go up the body's defenses to fight against herpes zoster. The aim of our study was to determine the action of aqueous extract of the leaves of Parkia biglobosa (Pb)and levels of total lymphocytes and CD4 + count in the blood of the rabbit.
MATERIALS AND METHODS

A. Materials
Plant material: The leaves of Parkia biglobosa (Mimosaceae) are collected in the botanical garden of the University of Cocody-Abidjan (Cote d'Ivoire). They were sorted, washed and dried in shade at room temperature 25 ± 2 °C. Thus, two hundred grams (200g) of the resulting powder were macerated in one (1) liter of distilled water for 24 hours. The macerate was filtered through two (2) times in clean cloth, then three (3) times on filter paper "Wattman. The filtrate is then allowed to dry for three (3) days in an oven at 50 °C to avoid deterioration of protein substances. The powder obtained after drying was dissolved in distilled water to give the aqueous extract of leaves of Parkia biglobosa (Pb). Thus, different concentrations were prepared to carry out the experiments.
Animals :
The rabbits of the species Orictolagus cumiculus whose age ranges from 3 to 4 months and weighing 1.5 ± 0.3 kg were caged in batches of six (6). The animals were supplied by a farm in the town of Bingerville in the district of Abidjan (Cote d'Ivoire). They were acclimated to the animal facility of the University of Cocody-Abidjan (Cote d'Ivoire) during two weeks before any experiment. The animals were fed with the pellets supplied by the Animal Food Manufacturing company Côte d'Ivoire (FACI ® ) and watered with tap water.
Chemicals :
The reference immunosuppressive used is methylprednisolone sodium scuccinate or Solu-M e d r o l ® a t 1 5 m g / k g B W f r o m P h a r m a c i a Laboratories ® (France). As for the reference immune stimulant, we used the Isoprinosine ® at 50mg/kg BM provided by Sanofi-Aventis (France).
B. Methods
Treatment of animals :
To determine the effect of aqueous extract of leaves of Parkia biglobosa (Pb) on TCD4+ and total lymphocytes, two types of experiments were performed. The first experiment was to highlight the dose-response effect of Pb. Thus, five (5) batches of six (6) rabbits were formed. Each group received intraperitoneally a single dose of Parkia biglobosa (25, 50, 75 and 100mg/kg BW) and a control group that received 0.9% NaCl. The second experiment was to carry out in the presence of an immunosuppressive reference (Méthyprednisolone, 15mg/kg BW) at doses of Pb (50, 75 and 100mg/kg BW) and a reference immunostimulator (Isoprinosine, 50mg/kg BW) (Litzman et al., 1999) . A blood sample was taken first day (D0) before the injection of various solutions and another on Day 3 (D3) after injection. Then more samples are taken each week (7 days) for 21 days. All blood samples were taken from the marginal vein of the ear of rabbit Whole blood is collected in EDTA tubes to prevent blood clotting. During the experiments, the animals' suffering was minimized under the terms of the Guide for Care and use of laboratory animals (National Academy Sciences, 1996) .
Dosage method : Part of the blood collected in EDTA tubes, was used to determine the rate by the total lymphocyte blood count done by hemogram on the Sysmex XT-2000i ® . As for the other part of the whole blood, it was used to determine the count of CD4 T lymphocytes by the method of Becton Dickinson (BD) Tritest (CD3 FITC/CD4 PE/CD45 par BM)by flow cytometry using the device BD Facscalibur ® . The method was to pipette 20µl of reagent BD Tritest CD3/CD4/CD45 in the bottom of the tubes BD FalconTM 12 x 75 mm. Then pipette 50µl of blood anticoagulated in the bottom of the same tubes that are capped and vortexed gently. The tubes are then incubated for 15 min in the dark at room temperature (20-25 °C). It was added 450µl of BD FACS lysis solution 1X into the tubes that are blocked and then vortexed gently. The tubes are incubated again for 15 min in the dark at room temperature (20-25 °C). Samples obtained will be analyzed on the flow cytometer. This method has been used by Bhagwat et al., (2009) for the determination of TCD4 + and TCD8+ cells in Balb/C Mice blood.
The principle of the method of flow cytometry analysis was based on the fact that during the addition of whole blood to the reagent, the antibodies labeled by fluorochromes and in the reagent BD Tritest bind specifically to surface antigens of leukocytes. Upon acquisition, the cells pass before the laser beam and diffract the laser light. The labeled cells fluoresce. These signals diffraction and fluorescence detected by the device, provide information about the size of the cell, its internal complexity and relative fluorescence intensity (Nicholson et al., 1993; Nicholson et al., 1996) .
Statistical analysis :
The software-grapPhad.Prism.V5.01.Retail-Keygen was used for statistical analysis. The data were analyzed with One-Way ANOVA. The nonparametric Dunnett's test was used for comparing the variance of control to other results. To compare the variances between them, the nonparametric test Kruskal-Wallis was used. The difference between two variances was significant if P<0.05.
RESULTS
1.
Dose-response effect of Parkia biglobosa (Pb) on immunological markers a-Action of Pb on the count of total lymphocytes
The dose-response effect of Pb on total lymphocytes, was shown in Figure 1 that the concentrations used (50, 75 and 100mg/kg BW) induced a significant increase in the average cell on Day 3 (D3) and 9th day (D9). Thus, the dose of 50mg/kg of BW induced a significant increase (P<0.001) on the average count of total lymphocytes on day 3 from 1753 ± 64.29 to 2051±52.85 copies/µl (18.96 ± 0 64%) and 2071 ± 78.65 copies/µl on Day 9 (20.28 ± 3.28%). Doses of 75 and 100mg/kg respectively BW have resulted in a significant increase in the average count of total lymphocytes from 21.21 ± 3.19% (P<0.0001) and 18.04 ± 1.92% (P<0.001) at day 3 before falling to 10.55 ± 0.98% (P<0.05) and 15.25 ± 1.32% (P<0.001) at 9th days (D9).
As for the dose of 25mg/kg of BW, it has induced a significant (P<0.001) average count of total lymphocytes only at D9 from (1753 ± 64.29 to 2186 ± 82.96 copies/µl). However, this increase induced by Pb is not dosedependent, since the peak on Day 9 of Pb25 curve is higher than the peaks of curves Pb50, Pb75 and Pb100 (Fig 1) .
b-Action of Pb on the TCD4+ count Figure 2 showed that in D3, only the doses Pb50, Pb75 and Pb100 had significantly increased the average count of CD4+. This increase is respectively from 140 ± 6 to157 ± 1.73 copies/µl, say 12.15 ± 3.76% (P<0.001), from 122 ± 10.44 to 149 ± 6.51 copies/pl, say 21.22 ± 8.80% (P<0.0001) and from 125 ± 6.08 to 137± 5.86 copies/µl, say 10.94 ± 0.60% (P<0.05) (Fig. 2) . At D3, Pb75 induced the highest average count CD4+ (149 ± 6.51 copies/pl). However, D9, apart from the doses of 50, 75, 100mg/kg of BW, the dose of 25mg/kg of BW also induced a significant increase of TCD4+ count (P<0.001) (Fig. 2) .
2. Parkia biglobosa and isoprinosine (Ip) action on the activity immunosupressing of Methylprednisolone (MP) a. P. biglobosa and isoprinosine action on the effect of Methylprednisolone on total lymphocyte According to Figure 3 , the mixture Methylprednisolone (15mg/kg BW ) or MP15 and Parkia biglobosa at different doses (50, 75 and 100mg/kg BW) did not cause significant variation in the average count of total lymphocytes of D3 to D21 compared to control (NaCl 0.9%). However, the mixture isoprinosine (50mg/kg BW) and MP (15mg/kg BW) increased significantly (P<0.001) the average count of total lymphocytes on day 3 (2590 ± 65.18 to 2860 ± 73.51 copies/µl), say 10.44 ± 1.91%. While at D3 and D9, MP15 single dose induced a significant decrease (P<0.0001) in the average count of total lymphocyte counts, respectively from -17.17 ± 2.53 to -14.77 ± 1.92%. Indeed, in Figure 3 , we note at D3, a significant difference between the count of only MP15 and mixtures MP15/Pb50 (P<0.001); MP15/Pb75 (P<0.0001); MP15/Pb100 (P<0.001); MP15/Ip50 (P<0.0001). b) Action of Pb and Ip on the effect of MP on CD4+ count Figure 4 showed that the dose of MP15 alone significantly decreased the average count of TCD4+ respectively from 125 ± 3.06 to 106 ± 4.36 copies/µl, say -15.33 ± 2.52% (P<0.001 ) and from 125 ± 3.06 to 113± 4.62 copies/µl; say -10.33 ± 2.52% (P<0.05). However, in the presence of methylprednisolone 15mg/kg BW, doses of Pb50, Pb75 and Pb100 have not resulted in significant variation of the average count of CD4+ on day 3 compared with the control (NaCl 0.9%) in contrast to Ip50 which induced a significant increase of 125 ± 3.06 to 139 ± 5.51 copies/µl (P<0.05) (Fig 4) . It is only at D9 that dose mentioned above have significantly increased the average count of CD4+ respectively 125 ± 3.06 to 145 ± 3.21 copies/pl (P<0.001), from 125 ± 3.06 to144 ± 2.31 copies/µl (P<0.001) and from 125 ± 3.06 to 141± 3.00 copies/µl (P<0.05). Furthermore, it should be noted that in D3 and D9, there exists a significant difference between the average count of TCD4+ induced by MP15 only and mixtures MP15/Pb50, 75, 100 (P<0.001); MP15/Ip50 (p<0.0001) (Figure 4 ).
Action Pb on the weight of rabbits
According to Table 1 , in the presence of aqueous extract of leaves of Parkia biglobosa, the animals gained weight throughout the experimental period. This weight gain is more pronounced with the dose of 75mg/kg of BW increased from 10.00% (D3) to 30.00% (D21). However, this increase is not significant. Also, we found that weight gain by animals in the presence of Pb25, Pb50, Pb75 is higher than that of animals in presence of NaCl 0.9% which is substantially the same as Pb100. (Table 1 ). (n = 6 for each batch).
The injected doses of Pb induced a significant increase in the average rate of cells at D3 and D9 with *** P<0.0001, ** P<0.001, * P<0.05. The injected doses of Pb induced a significant increase in the average count of CD4+ T cells at day 3 for Pb50, Pb75, and Pb100 andD9 for Pb25 , Pb50, Pb75, Pb100 with *** P<0.0001, ** P<0.001; * P<0.05. Lots of rabbits were treated with different doses of products: (□) Mp15mg/kg+Pb50 BW; (▲) Pb75+MP15mg/kg BW;  PB100+MP15mg/kg BW;  Ip50+MP15mg/kg BW; (n = 6 for each batch. Different doses of drugs injected induced a significant change in the average rate of total lymphocytes with (** P<0.001) (* P<0.05). The significant difference between the average count of total lymphocytes induced by the mixtures MP15/Ip50 and MP15/Pb50, 75, 100 is expressed by a: P<0.0001; b: P<0.001; c: P<0.05. The significant difference between the average rates of total lymphocytes induced by MP15 and the mixture MP15/Pb50, 75, 100 is expressed by α: P<0.0001; β: P<0.001, γ: P <0.05. The doses of mixtures indicated above have induced significant changes in the average count of CD4 +: *** P <0.0001, ** P <0.001, * P <0.05.
However, the significant difference between the average count of TCD4 induced by Ip50+MP15 and MP15+Pb is expressed as a: P<0.0001), b: P<0.001, c: P<0.05. As to the significant difference between the total average TCD4 induced by MP15 and the mixture MP15 + Pb is expressed by α: P<0.0001), β: P<0.001, γ: P<0.05.
